CN Stock MarketDetailed Quotes

002399 Shenzhen Hepalink Pharmaceutical Group

Watchlist
  • 10.36
  • +0.94+9.98%
Market Closed Apr 30 15:00 CST
15.20BMarket Cap-21856P/E (TTM)

Shenzhen Hepalink Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shenzhen Hepalink Pharmaceutical Group Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

1.37B

+5.55%
EPS(YoY)

0.11

+133.33%
Analyst Rating

Strong Buy

May 3, 2024

Shenzhen Hepalink Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2020/Q41.790B / ----
--2020/Q3883.279M / ----
--2020/Q21.257B / ----
--2020/Q11.402B / ----
DatePeriodRevenue/EstimateEarnings Call
--2020/Q41.790B / ----
--2020/Q3883.279M / ----
--2020/Q21.257B / ----
--2020/Q11.402B / ----

Shenzhen Hepalink Pharmaceutical Group Earnings Reports

  • Shenzhen Hepalink Pharmaceutical Group: 2024 First Quarter Report

    Apr 30 00:00

  • Highpree: Annual Report 2023

    Mar 29 00:00

  • Highpree: 2023 Annual Report Summary

    Mar 29 00:00

  • Hyperion: 2023 Annual Results Forecast

    Jan 31 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: May 3, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg